期刊文献+

寡肽转运体在生理、药物转运的重要作用及临床相关性 被引量:1

Vital role of oligopeptide transporters in physiology and drug transport and their clinical relevance
原文传递
导出
摘要 寡肽转运体(PEPTs)属于溶质转运体(SLC)大家族,以H^+梯度为驱动力,包括PEPT1和PEPT2。PEPT1是低亲和力、高容量转运蛋白,主要表达于小肠;而PEPT2是高亲和力、低容量的转运蛋白,主要在肾脏、脑和肺中表达,在生物体中分布较广。PEPTs除重吸收二肽和三肽以及维持脑中神经肽的稳态作用外,还能够吸收和处置许多重要的化合物,如一些氨基头孢菌素、血管紧张素转化酶抑制剂、抗病毒前药等,而且PEPTs也与一些肠道疾病和癌症相关。因此综述了PEPTs在生理、药物转运中的重要作用及临床相关性。 The oligopeptide transporters (PEPTs), including PEPT1 and PEPT2, belong to the SLC family and are driven by H+ gradient. PEPT1, the low-affinity and high-capacity transporter, is mainly expressed in small intestine, whereas PEPT2, the high-affinity and low-capacity transporter, is mainly expressed in kidney, brain and lung and has a broader distribution in the organism. The PEPTs are responsible for the absorption and conservation of dietary protein digestion products in intestine and kidney, respectively, and in maintaining homeostasis of neuropeptides in brain. They are also responsible for the absorption and disposition of a number of pharmacologically important compounds including some aminocephalosporins, angiotensin-converting enzyme inhibitors, antiviral prodrugs and others. And PEPTs are also associated with some intestinal diseases and cancer. Therefore, this article summarizes the important role of PEPTs in physiology and drug transport and their clinical relevance.
作者 舒蓉 刘克辛
出处 《药物评价研究》 CAS 2017年第9期1189-1196,共8页 Drug Evaluation Research
基金 国家自然科学基金项目(81473280)
关键词 寡肽转运体 组织分布 功能 oligopeptide transporters localization-expression function
  • 相关文献

参考文献2

二级参考文献87

  • 1于辉,李华,关绣霞,刘为民.小肽转运载体的分子营养学的研究进展[J].佛山科学技术学院学报(自然科学版),2005,23(3):77-80. 被引量:7
  • 2范淳,陈代文,余冰,杨玫.小肽转运载体(PepT1和PepT2)研究进展[J].饲料工业,2007,28(1):11-15. 被引量:4
  • 3Daniel H, Kottra G. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology [ J ] . Pflugers Arch, 2004, 447 ( 5 ) : 610-618.
  • 4Romano A, Barca A, Kottra G, Daniel H. Functional expression of SLC15 Peptide transporters in rat thyroid follicular cells [ J ] . Mol Cell Endoerinol, 2010, 315 ( 1 ) : 174-181.
  • 5Newstead S. Towards a structural understanding of alternating access within the proton dependent oligopeptide transporter ( POT ) family [ J ] . Biophysical Journal, 2012, 102 ( 3 ) : 605a.
  • 6Rubio-Aliaga I, Boll M, Daniel H. Cloning and characterization of the gene encoding the mouse peptide transporter PEPT2 [ J ] . Biochem Biophys Res Comnaun, 2000, 276 ( 2 ) : 734-741.
  • 7Terada T, Irie M, Okuda M, Inui K. Genetic variant Arg57His in human H+/peptide cotransporter2 causes a complete loss of transport function [ J ] . Biochem Biophys Res Commun, 2004, 316 ( 2 ) : 416-420.
  • 8Pedretti A, De Luca L, Marconi C, et al. Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping [ J ]. Bioorg Med Chem, 2011, 19 ( 15 ) : 4544-4551.
  • 9Oeheltree SM, Shen I-I, Hu Y J, Keep RF. Role and relevance of peptide transporter2 ( PEPT2 ) in the kidney and ehoroid plexus : in vivo studies with glycylsarcoine in wild-type and PEPT2 knockout mice [ J ] . J Pharmacol Exp Ther, 2005, 315 ( 1 ) : 240-247.
  • 10Biegel A, Knutter I, Hartrodt B, et al. The renal type H+/peptide symporter PEPT2 : Structure-affinity relationships [ J ] . Amino Acids, 2006, 31 ( 2 ) : 137-156.

共引文献7

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部